Millennium Pharmaceuticals, Inc. v. Aurobindo Pharma USA Inc. et al
Millennium Pharmaceuticals, Inc. |
Aurobindo Pharma Limited and Aurobindo Pharma USA Inc. |
1:2019cv00471 |
March 6, 2019 |
US District Court for the District of Delaware |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on March 7, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Summons Issued with Magistrate Consent Notice attached as to Aurobindo Pharma Limited on 3/7/2019; Aurobindo Pharma USA Inc. on 3/7/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sar) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 6,713,446 B2 ;6,958,319 B2. (sar) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: January 29, 2019. Date of Expiration of Patent: January 25, 2022.Thirty Month Stay Deadline: 7/29/2021. (sar) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sar) |
Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Aurobindo Pharma Limited, Aurobindo Pharma USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2587807.) - filed by Millennium Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(sar) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.